NIH Funding Announcements

Syndicate content
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 18 hours 20 min ago

Human Tumor Atlases (HTA) Precancer Atlas Research Centers (U2C)

Fri, 10/20/2017 - 03:54
Funding Opportunity RFA-CA-17-035 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research that results in a comprehensive view of the dynamic, multidimensional tumor ecosystem. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Generation of Human Tumor Atlases.
Categories: NIH-Funding

Human Tumor Atlases (HTA) Research Centers (U2C)

Fri, 10/20/2017 - 03:54
Funding Opportunity RFA-CA-17-034 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research that results in a comprehensive view of the dynamic multidimensional tumor ecosystem. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Generation of Human Tumor Atlases.
Categories: NIH-Funding

Human Tumor Atlas Network: Data Coordinating Center (U24)

Fri, 10/20/2017 - 03:53
Funding Opportunity RFA-CA-17-036 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research that results in a comprehensive view of the dynamic multidimensional tumor ecosystem. Specifically, this FOA targets the following area(s) designated as a scientific priority by the Blue Ribbon Panel (BRP): Generation of Human Tumor Atlases.
Categories: NIH-Funding

Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required)

Fri, 10/20/2017 - 03:39
Funding Opportunity PAR-18-332 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for support of clinical studies to repurpose existing drugs or biologics (therapeutics) that have already completed at least a Phase l trial for a different indication by the time an award is made. The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. Examples include independent crowdsourcing strategies (e.g., http://www.ncats.nih.gov/ntu/therapeutics/current, http://openinnovation.astrazeneca.com/, or any website that lists experimental drugs or biologics), or computational algorithms. Projects should be supported by scientific evidence that modulation of a therapeutic target will have a positive impact on the disease/condition. The U01 award may be used for Phase I and/or Phase II clinical trials for a new therapeutic use to establish substantial evidence of efficacy and to establish evidence of safety for the new use.
Categories: NIH-Funding

Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed)

Fri, 10/20/2017 - 03:10
Funding Opportunity PAR-18-331 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities.
Categories: NIH-Funding

Limited Competition: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10)

Fri, 10/20/2017 - 03:09
Funding Opportunity RFA-CA-17-058 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain a Canadian Collaborating Clinical Trials Network for the NCI National Clinical Trials Network (NCTN). The NCTN Canadian Collaborating Clinical Trials Network will be a full partner with the U.S. Network in the conduct of large-scale, multi-site clinical trials and help provide regulatory expertise/oversight for the conduct of NCTN trials in Canada. The competition for an award under this FOA is limited to eligible Canadian institutions.
Categories: NIH-Funding

NCI National Clinical Trials Network (NCTN)--Network Lead Academic Participating Sites (UG1)

Fri, 10/20/2017 - 03:09
Funding Opportunity RFA-CA-17-059 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain or establish Network Lead Academic Participating Sites (LAPS) for the NCI National Clinical Trials Network (NCTN). The NCTN Network LAPS will provide scientific leadership by helping to develop and conduct clinical trials in association with one or more adult Network Groups and will contribute substantial accrual to clinical trials conducted across the entire NCTN.
Categories: NIH-Funding

Limited Competition: NCI National Clinical Trials Network - Network Radiotherapy and Imaging Core Services Center (U24)

Fri, 10/20/2017 - 03:09
Funding Opportunity RFA-CA-17-060 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications to maintain a Network Radiotherapy and Imaging Core Services Center for the NCI National Clinical Trials Network (NCTN) that provides scientific and technical expertise for incorporating integrated quality assurance and image data management for applicable NCTN clinical trials that involve interventions with radiotherapy and/or imaging modalities. In addition, the Center will have the capacity to provide similar services for other approved NCI-supported clinical trials network programs (e.g., the NCI/DCTD early phase clinical trial network program and the NCI/DCP NCI Community Oncology Research Program).
Categories: NIH-Funding

NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1)

Fri, 10/20/2017 - 03:09
Funding Opportunity RFA-CA-17-061 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain or establish Network Group Integrated Translational Science Centers for the NCI National Clinical Trials Network (NCTN). The NCTN Network Group Integrated Translational Science Centers will provide support for leadership and expertise to facilitate incorporating translational science into Network Group clinical trials, including the conduct of pilot projects to collect preliminary data.
Categories: NIH-Funding

Investigator-Initiated Clinical Trials Targeting Diseases within the Mission of NIDDK (R01-Clinical Trial Required)

Fri, 10/20/2017 - 02:49
Funding Opportunity PA-18-330 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for investigator-initiated clinical trials within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to be conducted at no more than two clinical research centers. NIDDK is committed to improving the health of people with diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic and hematologic diseases. Applications for clinical trials submitted under this FOA should be hypothesis driven, have clearly described aims and objectives, and have a high likelihood that the trial findings will improve understanding, diagnosis, prevention or treatment of the diseases studied and have the potential to impact clinical practice and/or public health.
Categories: NIH-Funding

Maintaining Immunity After Immunization (U01 - Clinical Trial Optional)

Fri, 10/20/2017 - 02:36
Funding Opportunity RFA-AI-17-034 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to improve understanding of how durable protective immunity is achieved by supporting studies that define components and mechanisms of the immune system. Applications proposing human cells/tissue response studies will help determine the human responses elicited by immunization, however, animal studies may also be used to extend the findings from human tissues to more mechanistic studies not easily accomplished in humans.
Categories: NIH-Funding

Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10)

Thu, 10/19/2017 - 03:09
Funding Opportunity RFA-CA-17-056 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain a Network Group Operations Center for the NCI National Clinical Trials Network (NCTN). The NCTN Network Group Operations Centers will provide scientific leadership for developing and implementing multi-disciplinary, multi-institutional trials in a range of cancer types and special populations with specific scientific strategy and goals.
Categories: NIH-Funding

Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10)

Thu, 10/19/2017 - 03:09
Funding Opportunity RFA-CA-17-057 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain Network Group Statistics and Data Management Centers (SDMCs) for the NCI National Clinical Trials Network (NCTN). The NCTN Network SDMCs will provide statistical expertise for effective scientific design, conduct, and data management of clinical trials led by the associated NCTN Network Group Operations Center.
Categories: NIH-Funding

Research Centers for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (UM1)

Wed, 10/18/2017 - 11:16
Funding Opportunity RFA-CA-17-042 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative established to accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): the Implementation of Integrated and Evidenced-based Symptom Management Throughout the Cancer Trajectory. The purpose of this specific FOA is to promote research on the implementation and evaluation of integrated symptom monitoring and management systems for use in cancer care delivery through a Research Consortium. This research will provide new insights and valuable evidence that can be used to guide efforts on a nation-wide basis to improve symptom control for cancer patients during treatment and survivorship.
Categories: NIH-Funding

Coordinating Center for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (U24)

Wed, 10/18/2017 - 11:15
Funding Opportunity RFA-CA-17-043 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative established to accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): the Implementation of Integrated and Evidenced-based Symptom Management Throughout the Cancer Trajectory. The purpose of this specific FOA is to promote research on the implementation and evaluation of comprehensive symptom management systems for use in cancer care delivery through a Research Consortium. This research will provide new insights and valuable evidence that can be used to guide efforts on a nation-wide basis to improve symptom control for cancer patients during treatment and survivorship.
Categories: NIH-Funding

Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC3H) (UG3/UH3)

Wed, 10/18/2017 - 10:45
Funding Opportunity RFA-HD-18-032 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to stimulate much needed research in an important area of public health significance: prevention of new HIV infections among adolescents at risk, and the identification of, linkage to and retention in care of, and long term viral suppression among youth living with HIV in low-to-middle income countries. These settings must have an HIV epidemic density defined by UNAIDS estimates as either a country 1) in which at least 200,000 people are living with HIV and the number has not decreased by more than 5% over the last 2 consecutive years of available data or 2) has an HIV prevalence of 3% or more. The UG3/UH3 Phased Innovation Awards Cooperative Agreement involves 2 phases. Funding for a UG3 phase will be used to demonstrate sufficient preparation, feasibility and capacity to meet foundational milestone targets specific to the work proposed. A UG3 project that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award. Applicants responding to this FOA must address objectives for both the UG3 and UH3 phases.
Categories: NIH-Funding

NHLBI Announces Plans to Fund a Jackson Heart Study Exam 4

Wed, 10/18/2017 - 02:52
Notice NOT-HL-17-542 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)

Tue, 10/17/2017 - 12:42
Funding Opportunity PAR-18-324 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to fund highly innovative and promising research that tests multi-level physical activity intervention programs acting on at least two levels of the socio-ecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity; and 2) that could be made scalable and sustainable for broad use across the nation. This FOA provides support for up to 5 years for research planning, intervention delivery, and follow-up activities.
Categories: NIH-Funding

Notice of Upcoming Webinar for the Jackson Heart Study Renewal - Field Center

Tue, 10/17/2017 - 09:51
Notice NOT-HL-17-555 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding